1-5 of 5
Priscilla B. Caguioa
Close
Sort by
Journal Articles

Final Study Results of Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 48 Months Follow-up

Young Rok Do, PhDMD, Jae-Yong Kwak, MD PhD, Hawk Kim, MDPhD, Jeong-A Kim, MD PhD, Hyeoung-Joon Kim, MD PhD, Joon Seong Park, MD, Jooseop Chung, MD PhD, Ho-Jin Shin, MD PhD, Sung-Hyun Kim, MD PhD, Udomsak Bunworasate, MD, Chul Won Choi, MD PhD, Narcisa Sonia Cornejo Comia, MD, Dae Young Zang, MDPhD, Sukjoong Oh, MDPhD, Saengsuree Jootar, MD, Ary Harryanto Reksodiputro, MDPhD, Won-Sik Lee, MD, Yeung-Chul Mun, MD PhD, Jee Hyun Kong, MD, Priscilla B. Caguioa, MD, Jinny Park, MD PhD, Chul W. Jung, MD PhD, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1733.
https://doi.org/10.1182/blood-2018-99-110568
Published: 2018
Journal Articles

Deeper Molecular Response in Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia Chronic Phase (CML-CP) Patients Receiving Radotinib 300 Mg BID or Imatinib: Rerise 36 Months Follow-up

Young Rok Do, MD PhD, Hawk Kim, MD PhD, Jae-Yong Kwak, Jeong-A Kim, Hyeoung-Joon Kim, Joon Seong Park, MD, Jooseop Chung, MD PhD, Ho-Jin Shin, MD PhD, Sung-Hyun Kim, MD PhD, Udomsak Bunworasate, MD, Chul Won Choi, MD PhD, Narcisa Sonia Cornejo Comia, MD, Dae Young Zang, Sukjoong Oh, Saengsuree Jootar, MD, Ary Harryanto Reksodiputro, MDPhD, Won-Sik Lee, MD, Yeung-Chul Mun, MD PhD, Jee Hyun Kong, Priscilla B. Caguioa, MD, Jinny Park, MD PhD, Chul W. Jung, MD PhD, Dong-Wook Kim, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 317.
https://doi.org/10.1182/blood.V130.Suppl_1.317.317
Published: 2017
Journal Articles

Efficacy and Safety of Radotinib Compared with Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Patients: 12 Months Result of Phase 3 Clinical Trial

Jae-Yong Kwak, Hawk Kim, Jeong A Kim, Young Rok Do, Hyeoung Joon Kim, MD PhD, Joon Seong Park, Joo Seop Chung, MD PhD, Ho-Jin Shin, Sung-Hyun Kim, Dae-Young Kim, MD PhD, Udomsak Bunworasate, Chul Won Choi, MD PhD, Narcisa Sonia Cornejo Comia, Dae Young Zang, Sukjoong Oh, Saengsuree Jootar, Ary Harryanto Reksodiputro, Won Sik Lee, Yeung-Chul Mun, Jee Hyun Kong, Priscilla B. Caguioa, Jinny Park, Chul Won Jung, Dong-Wook Kim
Journal: Blood
Blood (2015) 126 (23): 476.
https://doi.org/10.1182/blood.V126.23.476.476
Published: 2015
Journal Articles

Predictive Value of 3-Month Early Molecular Response in New Chronic Phase Chronic Myeloid Leukemia Patients Treated with Radotinib

Sung-Eun Lee, MD, Soo Young Choi, Jae-Yong Kwak, Hawk Kim, Jeong-A Kim, MDPhD, Young Rok Do, Hyeoung Joon Kim, Joon Seong Park, Joo Seop Chung, MD PhD, Ho-Jin Shin, Sung-Hyun Kim, Dae-Young Kim, MD PhD, Udomsak Bunworasate, Chul Won Choi, Narcisa Sonia Cornejo Comia, Dae Young Zang, Sukjoong Oh, Saengsuree Jootar, Ary Harryanto Reksodiputro, Won Sik Lee, Yeung-Chul Mun, Jee Hyun Kong, Priscilla B. Caguioa, Jinny Park, Chul Won Jung, Dong-Wook Kim
Journal: Blood
Blood (2015) 126 (23): 4053.
https://doi.org/10.1182/blood.V126.23.4053.4053
Published: 2015
Journal Articles

A Phase 1/2 Study Of KW-2478, An Hsp 90 Inhibitor, In Combination With Bortezomib (BTZ) In Patients (Pts) With Relapsed/Refractory (R/R) Multiple Myeloma (MM)

Cavanagh Jamie, MD, Honorata Giongco Baylon, MD, Priscilla B. Caguioa, MD, Faith E. Davies, MD, Mecide Gharibo, MD, Shiro Akinaga, PhD, Michael R. Kurman, MD, Barbara A. Novak, BS, Kwee L. Yong, PhD
Journal: Blood
Blood (2013) 122 (21): 1967.
https://doi.org/10.1182/blood.V122.21.1967.1967
Published: 2013